"The
global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009
with first lot of doses being commercialized on 30th September’ 2009. The market
will see a high CAGR for the next two years i.e. the market is expected to be at
$7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very
high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The
reason for the sudden settle down of the growth is that it is expected that most
of the world population will be immunized by the end of 2011."
Rest Of World H1N1 (swine flu) Vaccination Market
http://blog.taragana.com/pr/rest-of-world-h1n1-swine-flu-vaccination-market-8386/
admin
November 2nd, 2009
Opportunity Analysis of H1N1 (swine flu) Vaccination Market report (
http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html
) assess that H1N1 Influenza A (2009) is the first pandemic influenza of 21st
century affecting more than four lac people in more than 180 countries across
the globe in 2009. The flu broke in Mexico in the month of March and then
affected U.S. and after that it spread across the globe. H1N1 (2009) influenza
have a mutation of pig, bird and humans which has made it more dangerous and
fatal compared to previous occurrence of H1N1 (1918).
The pandemic outbreak of the influenza opened the gates for the drugs such as
Tamiflu in the initial phase for the curing of the disease but the following
phase will see a shift from curing to prevention. Thus, arise the requirement
for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast
for the upcoming vaccines for the prevention of the disease among the unaffected
population. The vaccines market is classified for the intramuscular vaccines and
intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the
remaining will be tapped by the intranasal vaccines. The initial lot of vaccines
will be of egg based and cell based manufacturing. The market forecast is from
late 2009 as the first lot of doses are expected to be rolled out in the first
week of October 2009.
The first movers of the in the vaccines market are Glaxo Smith Kline (GSK),
Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the
only producer of the intranasal vaccine whereas other companies are expected to
come out with intramuscular vaccines. The companies have got approvals for their
first lots from the governments of the various countries such as U.S., U.K.,
France, China, Denmark and Australia. The involvement of government bodies,
increased awareness about prevention and pandemic situation of the influenza is
driving the market for the vaccines. Due to intensive ongoing research and
technology introduction, the market players are compelled to understand the
market dynamics, innovations, pricing, products, marketing and regulatory
framework of the market.
The global H1N1 Influenza vaccine market is estimated to be of 676 million in
2009 with first lot of doses being commercialized on 30th September’ 2009. The
market will see a high CAGR for the next two years i.e. the market is expected
to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However,
the very high CAGR will settle down by 2012 to 30% for the period of 2009 to
2012. The reason for the sudden settle down of the growth is that it is expected
that most of the world population will be immunized by the end of 2011.
Market estimates and forecast
* This report will enable strategic understanding and opportunities in the H1N1
2009 influenza vaccines market. The report covers the following market segments.
* Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.
* Geography Markets: North America, Europe, Asia-Pacific and ROW
Each section of the report offers market data with respect to segments and
geography. It also provides market trends with respect to drivers, restraints
and opportunities. The report contains strategic section with respect to
competitive landscape and market overview. The report will encompass around 15
company profiles.
To know more and to buy a copy of your report feel free to visit :
http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html
Or
Contact us at :
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website:
www.bharatbook.com
Blog:
http://bharatbookresearch.blogspot.com
Follow us on twitter:
http://twitter.com/3bbharatbook